GlobeNewswire Inc.··Researchandmarkets.ComCheckpoint Inhibitor Market Analysis: 50+ Players Drive Immuno-Oncology Innovation Through 2026
Over 50 companies compete in the checkpoint inhibitor market with 60+ drug candidates in development. Major consolidation and innovation drive immuno-oncology growth through 2026.
BMYCELGrKYKOYRNAZclinical trialscompetitive landscape